Rituximab for the treatment of acute onset Interstitial Lung Disease in primary Sjogren's syndrome

Ítems similars

• Rituximab for the treatment of acute onset Interstitial Lung Disease in primary Sjogren's syndrome
  per: Giulia Klinowski, et al.
  Publicat: (2021-11-01)
• COVID-19, A New Possible Mimicker of Interstitial Lung Disease Related to Primary Sjögren’s Syndrome
  per: Alessia Laneri, et al.
  Publicat: (2023-01-01)
• Genetic Risk Factors in Idiopathic and Non-Idiopathic Interstitial Lung Disease: Similarities and Differences
  per: Stefania Cerri, et al.
  Publicat: (2024-11-01)
• Rituximab for Early-Onset Juvenile Dermatomyositis Complicated by Interstitial Lung Disease
  per: M. Olszewska, et al.
  Publicat: (2025-01-01)
• Rituximab in Antimelanoma Differentiation-Associated Protein-5 Dermatomyositis with Interstitial Lung Disease
  per: Chiara Scirocco, et al.
  Publicat: (2020-01-01)